Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy

BMC Cancer201212:612

DOI: 10.1186/1471-2407-12-612

Received: 29 March 2012

Accepted: 18 December 2012

Published: 21 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Jun 2012 Reviewed Reviewer Report - Timothy Yap
11 Jun 2012 Reviewed Reviewer Report - Nicolas Chapuis
31 Aug 2012 Author responded Author comments - Jussi Koivunen
Resubmission - Version 3
31 Aug 2012 Submitted Manuscript version 3
6 Oct 2012 Reviewed Reviewer Report - Timothy Yap
9 Oct 2012 Reviewed Reviewer Report - Nicolas Chapuis
30 Nov 2012 Author responded Author comments - Jussi Koivunen
Resubmission - Version 4
30 Nov 2012 Submitted Manuscript version 4
Publishing
18 Dec 2012 Editorially accepted
21 Dec 2012 Article published 10.1186/1471-2407-12-612

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medical Oncology and Radiotherapy, Oulu University Hospital

Advertisement